B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)

• Váldodahkkit: Adam Klocperk (Dahkki), Marketa Bloomfield (Dahkki), Zuzana Parackova (Dahkki), Ludovic Aillot (Dahkki), Jiri Fremuth (Dahkki), Lumir Sasek (Dahkki), Jan David (Dahkki), Filip Fencl (Dahkki), Aneta Skotnicova (Dahkki), Katerina Rejlova (Dahkki), Martin Magner (Dahkki), Ondrej Hrusak (Dahkki), Anna Sediva (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SpringerOpen, 2023-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Čoahkkáigeassu

Abstract Background Multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C) is a late complication of pediatric COVID-19, which follows weeks after the original SARS-CoV-2 infection, regardless of its severity. It is characterized by hyperinflammation, neutrophilia, lymphopenia, and activation of T cells with elevated IFN-γ. Observing the production of autoantibodies and parallels with systemic autoimmune disorders, such as systemic lupus erythematodes (SLE), we explored B cell phenotype and serum levels of type I, II, and III interferons, as well as the cytokines BAFF and APRIL in a cohort of MIS-C patients and healthy children after COVID-19. Results We documented a significant elevation of IFN-γ, but not IFN-α and IFN-λ in MIS-C patients. BAFF was elevated in MIS-C patient sera and accompanied by decreased BAFFR expression on all B cell subtypes. The proportion of plasmablasts was significantly lower in patients compared to healthy post-COVID children. We noted the pre-IVIG presence of ENA Ro60 autoantibodies in 4/35 tested MIS-C patients. Conclusions Our work shows the involvement of humoral immunity in MIS-C and hints at parallels with the pathophysiology of SLE, with autoreactive B cells driven towards autoantibody production by elevated BAFF. Graphical Abstract

Fuomášahttimat

10.1186/s40348-023-00169-z
2194-7791